Logo-apb
Adv Pharm Bull. 2023;13(1): 176-187. doi: 10.34172/apb.2023.019
PMID: 36721820        PMCID: PMC9871276

Research Article

Ferroptosis as a Potential Cell Death Mechanism Against Cisplatin-Resistant Lung Cancer Cell Line

Morteza Golbashirzadeh 1,2 ORCID, Hamid Reza Heidari 1,2 * ORCID, Mehdi Talebi 3, Ahmad Yari Khosroushahi 1,4 * ORCID

Cited by CrossRef: 5


1- Qin C, Yuan J, Zhang R, Liu L, Ban Y. 24-Dehydrocholesterol Reductase Facilitates Cisplatin Resistance of Non-small Cell Lung Cancer via Repressing Reactive Oxygen Species/Ferroptosis Pathway. Iran J Pharm Res. 2024;23(1) [Crossref]
2- Wang H, Liu Y, Che S, Li X, Tang D, Lv S, Zhao H. Deciphering the link: ferroptosis and its role in glioma. Front Immunol. 2024;15 [Crossref]
3- Liang Q, Wang Y, Li Y, Wang J, Liu C, Li Y. Ferroptosis: emerging roles in lung cancer and potential implications in biological compounds. Front Pharmacol. 2024;15 [Crossref]
4- Wang Y, Hu J, Fleishman J, Li Y, Ren Z, Wang J, Feng Y, Chen J, Wang H. Inducing ferroptosis by traditional medicines: a novel approach to reverse chemoresistance in lung cancer. Front Pharmacol. 2024;15 [Crossref]